Effect Of Once-Weekly Semaglutide on Weight Change and Metabolic Control in People with Type 1 Diabetes-Six-Months Results from the Real-World STEMT Trial

被引：0
|
作者：
Mertens, Jonathan
de Winter, Hennah T.
Mazlom, Hadi
Peiffer, Frida W.
Dirinck, Eveline L.
Bochanen, Niels
Van Gaal, Luc F.
de Block, Christophe
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-751-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
751-P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Once-Weekly Semaglutide in People with Type 1 Diabetes in Real-World Practice
    Bellido, Virginia
    Herguido, Noelia Gros
    Amuedo, Sandra
    Ariza, Luis Baena
    Alfonso, Soto M.
    DIABETES, 2023, 72
  • [2] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
    Menzen, Markus
    Berentzen, Tina Landsvig
    Catarig, Andrei-Mircea
    Pieperhoff, Sebastian
    Simon, Joerg
    Jacob, Stephan
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (04) : 205 - 215
  • [3] Real-world use of once-weekly semaglutide in type 2 diabetes: Results from the SURE UK study
    Holmes, P.
    Catarig, A. M.
    Clark, A.
    Erhan, U.
    Sathyapalan, T.
    DIABETIC MEDICINE, 2021, 38
  • [4] Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme
    Yale, Jean-Francois
    Major-Pedersen, Atheline
    Catarig, Andrei-Mircea
    Jain, Rashmi
    Menzen, Markus
    Holmes, Patrick
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4429 - 4440
  • [5] Real-World Impact of Once-Weekly Injectable Semaglutide on Glycemic Control and Weight Outcomes in Type 2 Diabetes (RELATE-OW Injectable Semaglutide)
    Amamoo, James
    Doshi, Riddhi P.
    Noone, Joshua
    Tan, Xi
    Xie, Lin
    Gamble, Cory L.
    Guevarra, Mico
    Chen, Justin
    King, Aaron A.
    DIABETES, 2023, 72
  • [6] Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain
    Garcia de Lucas, Maria Dolores
    Pablo Miramontes-Gonzalez, Jose
    Aviles-Bueno, Beatriz
    Isabel Jimenez-Millan, Ana
    Rivas-Ruiz, Francisco
    Perez-Belmonte, Luis M.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Safety profile of once-weekly subcutaneous semaglutide in a real-world adult population with type 2 diabetes
    Yale, J. -F.
    Major-Pedersen, A.
    Catarig, A. -M.
    Jain, R. G.
    Menzen, M.
    Holmes, P.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S339 - S340
  • [8] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
    Holmes, Patrick
    Bell, Heather Elizabeth
    Bozkurt, Karan
    Catarig, Andrei-Mircea
    Clark, Alice
    Machell, Alena
    Sathyapalan, Thozhukat
    DIABETES THERAPY, 2021, 12 (11) : 2891 - 2905
  • [9] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
    Patrick Holmes
    Heather Elizabeth Bell
    Karan Bozkurt
    Andrei-Mircea Catarig
    Alice Clark
    Alena Machell
    Thozhukat Sathyapalan
    Diabetes Therapy, 2021, 12 : 2891 - 2905
  • [10] Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
    Wolffenbuttel, Bruce H. R.
    Brugts, Michel P.
    Catarig, Andrei-Mircea
    Clark, Alice
    Kok, Maarten
    Lieverse, Aloysius G.
    van Soest, Jaap
    ADVANCES IN THERAPY, 2023, 40 (03) : 920 - 933
12345